RenovoRx Expands RenovoCath Patent Protection for Cancer
Mountain View, California, U.S. | August 20, 2026 RenovoRx announced that the U.S. Patent and Trademark Office (USPTO) has...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Mountain View, California, U.S. | August 20, 2026 RenovoRx announced that the U.S. Patent and Trademark Office (USPTO) has...
SARASOTA, Fla., June 29, 2026 Silo Pharma announced that it has initiated a drug-device robustness study for SPC-15, its...
INDIANAPOLIS / LEHIGH VALLEY, Pa., Jan. 30, 2026 — Eli Lilly announced plans to invest more than $3.5 billion...
MAHWAH, N.J., January 29, 2026 — KORU Medical Systems has received U.S. FDA 510(k) clearance expanding the labeled use...
Westminster, Colo., Jan. 13, 2026 — Cerapedics Inc. announced that the U.S. Food and Drug Administration (FDA) has approved...
RANCHO CUCAMONGA, Calif. — December 15, 2025 — Amphastar Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration...
